Condition
Platelet Aggregation Inhibitors clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Platelet Aggregation Inhibitors clinical trials that are recruiting, at sites in 6 countries (most in Italy (2), France (1), United States (1)). By phase: Phase 4 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 6Countries
Newest Platelet Aggregation Inhibitors clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Personalized blood-thinner plan for leg artery disease after repair | — | Boston, Massachusetts and 1 other locations | Recruiting | May 29, 2026 |
| Single versus dual antiplatelet therapy after drug-coated balloon angioplasty in elderly or high-bleeding-risk patients | — | Milan, MI | Recruiting | Aug 2, 2024 |
| Using an algorithm to tailor antiplatelet therapy after heart procedures | — | Banja Luka and 3 other locations | Recruiting | Feb 17, 2023 |
| Assessing the effects of enteric-coated aspirin in patients with type 2 diabetes | Phase 1 | Montreal, Quebec | Recruiting | Jan 27, 2023 |
| Aspirin alone vs aspirin plus clopidogrel after left atrial appendage closure | Phase 4 | Pessac and 1 other locations | Recruiting | Mar 15, 2021 |
All recruiting trials (5)
-
Personalized blood-thinner plan for leg artery disease after repair
A personalized plan using a blood test to tailor antiplatelet therapy is being tested against standard treatment in adults with PAD after a procedure to restore blood flow.
-
Single versus dual antiplatelet therapy after drug-coated balloon angioplasty in elderly or high-bleeding-risk patients
This study tests whether taking one antiplatelet medicine is as safe and causes less bleeding than taking two medicines for people aged 75 or older, or adults at high bleeding risk, after drug-coated balloon angioplasty for coronary artery disease.
-
Using an algorithm to tailor antiplatelet therapy after heart procedures
This study is testing whether using a special scoring system to decide how long heart patients should take their blood-thinning medication after getting a stent can lead to better health outcomes compared to the usual method.
-
Assessing the effects of enteric-coated aspirin in patients with type 2 diabetes
This study is testing different doses of enteric-coated aspirin to see which one works best for people with type 2 diabetes who don’t respond well to a standard dose.
-
Aspirin alone vs aspirin plus clopidogrel after left atrial appendage closure
This phase 4 trial tests whether aspirin alone or aspirin with clopidogrel after left atrial appendage closure reduces brain lesions and improves outcomes.
Related topics
Quick answers
How many Platelet Aggregation Inhibitors clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in Italy (2 trials), France (1 trial), United States (1 trial), Bosnia and Herzegovina (1 trial), Switzerland (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.